London
· Delayed Price · Currency is GBP · Price in USD BioPharma Credit Statistics
Total Valuation
LON:BPCR has a market cap or net worth of GBP 724.60 million. The enterprise value is 720.38 million.
| Market Cap | 724.60M |
| Enterprise Value | 720.38M |
Important Dates
The last earnings date was Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | Apr 3, 2025 |
Share Statistics
LON:BPCR has 1.13 billion shares outstanding. The number of shares has decreased by -6.65% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.13B |
| Shares Change (YoY) | -6.65% |
| Shares Change (QoQ) | -3.81% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 85.21% |
| Float | 990.99M |
Valuation Ratios
The trailing PE ratio is 8.54.
| PE Ratio | 8.54 |
| Forward PE | n/a |
| PS Ratio | 6.05 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 8.11 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 7.38 |
| EV / Sales | 6.39 |
| EV / EBITDA | n/a |
| EV / EBIT | 7.85 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.09
| Current Ratio | 2.09 |
| Quick Ratio | 2.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.69% and return on invested capital (ROIC) is 6.05%.
| Return on Equity (ROE) | 9.69% |
| Return on Assets (ROA) | 5.97% |
| Return on Invested Capital (ROIC) | 6.05% |
| Return on Capital Employed (ROCE) | 10.34% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.73% in the last 52 weeks. The beta is 0.14, so LON:BPCR's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -2.73% |
| 50-Day Moving Average | 0.87 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 47.99 |
| Average Volume (20 Days) | 737,457 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:BPCR had revenue of GBP 119.84 million and earned 97.59 million in profits. Earnings per share was 0.08.
| Revenue | 119.84M |
| Gross Profit | 119.84M |
| Operating Income | 97.59M |
| Pretax Income | 97.59M |
| Net Income | 97.59M |
| EBITDA | n/a |
| EBIT | 97.59M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 4.49 million in cash and n/a in debt, giving a net cash position of 4.49 million or 0.00 per share.
| Cash & Cash Equivalents | 4.49M |
| Total Debt | n/a |
| Net Cash | 4.49M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 943.89M |
| Book Value Per Share | 0.80 |
| Working Capital | 15.60M |
Cash Flow
| Operating Cash Flow | 89.39M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 81.44% and 81.44%.
| Gross Margin | 100.00% |
| Operating Margin | 81.44% |
| Pretax Margin | 81.44% |
| Profit Margin | 81.44% |
| EBITDA Margin | n/a |
| EBIT Margin | 81.44% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 11.87%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 11.87% |
| Dividend Growth (YoY) | -2.99% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 89.23% |
| Buyback Yield | 6.65% |
| Shareholder Yield | 18.52% |
| Earnings Yield | 13.47% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:BPCR has an Altman Z-Score of 37.35.
| Altman Z-Score | 37.35 |
| Piotroski F-Score | n/a |